Tarsus Pharmaceuticals Stock Options
| TARS Stock | USD 46.52 0.40 0.85% |
Tarsus Pharmaceuticals' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 0.81 with a put-to-call open interest ratio of 0.3 over 23 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
Tarsus Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Tarsus Pharmaceuticals' lending market. For example, when Tarsus Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Tarsus Pharmaceuticals, he or she must hedge the risk by shorting Tarsus Pharmaceuticals stock over its option's life.
2025-04-17
The chart above shows Tarsus Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Tarsus Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Tarsus Pharmaceuticals' option, there is no secondary market available for investors to trade.
Tarsus Pharmaceuticals Maximum Pain Price Across 2025-04-17 Option Contracts
Max pain occurs when Tarsus Pharmaceuticals' market makers reach a net positive position across all Tarsus Pharmaceuticals' options at a strike price where option holders stand to lose the most money. By contrast, Tarsus Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Tarsus Pharmaceuticals
Analyzing Tarsus Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Tarsus Pharmaceuticals regardless of its overall volatility. This is especially true when Tarsus Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Tarsus Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Tarsus Pharmaceuticals' stock while costing only a fraction of its price.
Tarsus Pharmaceuticals In The Money Call Balance
When Tarsus Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Tarsus Pharmaceuticals stock is said to be in the money. When it comes to buying Tarsus Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Tarsus Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Tarsus Current Options Market Mood
Tarsus Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Tarsus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Tarsus Pharmaceuticals' options investors are not very successful. Tarsus Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Tarsus contract
Base on the Rule 16, the options market is currently suggesting that Tarsus Pharmaceuticals will have an average daily up or down price movement of about 0.0506% per day over the life of the 2025-04-17 option contract. With Tarsus Pharmaceuticals trading at USD 46.52, that is roughly USD 0.0236. If you think that the market is fully incorporating Tarsus Pharmaceuticals' daily price movement you should consider buying Tarsus Pharmaceuticals options at the current volatility level of 0.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Tarsus |
Purchasing Tarsus Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Tarsus calls. Remember, the seller must deliver Tarsus Pharmaceuticals stock to the call owner when a call is exercised.
Tarsus Pharmaceuticals Option Chain
When Tarsus Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Tarsus Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Tarsus Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Tarsus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Tarsus. It also shows strike prices and maturity days for a Tarsus Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TARS250417C00030000 | 23 | 30.0 | 15.0 - 19.9 | 24.5 | In |
Call | TARS250417C00035000 | 0 | 35.0 | 10.7 - 15.4 | 10.7 | In |
Call | TARS250417C00040000 | 21 | 40.0 | 7.6 - 12.4 | 8.6 | In |
Call | TARS250417C00045000 | 9 | 45.0 | 4.6 - 9.4 | 11.0 | In |
Call | TARS250417C00050000 | 14 | 50.0 | 2.8 - 7.5 | 5.11 | Out |
Call | TARS250417C00055000 | 17 | 55.0 | 1.7 - 6.0 | 8.0 | Out |
Call | TARS250417C00060000 | 28 | 60.0 | 0.7 - 5.0 | 8.2 | Out |
Call | TARS250417C00065000 | 20 | 65.0 | 0.3 - 4.9 | 5.0 | Out |
Call | TARS250417C00070000 | 0 | 70.0 | 0.1 - 4.9 | 0.1 | |
Call | TARS250417C00075000 | 3 | 75.0 | 0.0 - 4.9 | 3.9 | Out |
Call | TARS250417C00080000 | 2 | 80.0 | 0.0 - 4.9 | 2.8 | Out |
Put | TARS250417P00025000 | 10 | 25.0 | 0.0 - 4.9 | 0.95 | Out |
Put | TARS250417P00030000 | 15 | 30.0 | 0.5 - 5.0 | 1.05 | Out |
Put | TARS250417P00035000 | 3 | 35.0 | 0.1 - 4.9 | 1.67 | Out |
Put | TARS250417P00040000 | 4 | 40.0 | 0.5 - 4.9 | 3.5 | Out |
Put | TARS250417P00045000 | 8 | 45.0 | 2.8 - 7.5 | 5.3 | Out |
Put | TARS250417P00050000 | 1 | 50.0 | 5.7 - 10.4 | 5.0 | In |
Put | TARS250417P00055000 | 0 | 55.0 | 9.2 - 13.9 | 9.2 | In |
Put | TARS250417P00060000 | 0 | 60.0 | 13.2 - 18.0 | 13.2 | In |
Put | TARS250417P00065000 | 0 | 65.0 | 17.7 - 22.5 | 17.7 | In |
Put | TARS250417P00070000 | 0 | 70.0 | 22.1 - 26.9 | 22.1 | In |
Put | TARS250417P00075000 | 0 | 75.0 | 26.7 - 31.5 | 26.7 | In |
Put | TARS250417P00080000 | 0 | 80.0 | 31.7 - 36.5 | 31.7 | In |
Tarsus Total Stockholder Equity
Total Stockholder Equity |
|
Tarsus Pharmaceuticals Corporate Management
| Leonard JD | Chief Officer | Profile | |
| Scott Youmans | Vice Sales | Profile | |
| Seshadri Neervannan | Chief Officer | Profile | |
| Adrienne Kemp | Senior Communications | Profile | |
| Elizabeth MD | Chief Director | Profile | |
| Aziz MBA | Chief Officer | Profile |
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.